BlackRock Health Sciences Opps Inv C
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-2.0%
1 yr return
-9.0%
3 Yr Avg Return
-2.0%
5 Yr Avg Return
3.0%
Net Assets
$9.49 B
Holdings in Top 10
41.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.84%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 19.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
SHSCX - Profile
Distributions
- YTD Total Return -2.0%
- 3 Yr Annualized Total Return -2.0%
- 5 Yr Annualized Total Return 3.0%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.77%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameBlackRock Health Sciences Opportunities Portfolio
-
Fund Family NameBlackRock
-
Inception DateOct 16, 2000
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerErin Xie
Fund Description
SHSCX - Performance
Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -2.0% | -25.6% | 24.5% | 73.18% |
1 Yr | -9.0% | -28.9% | 21.2% | 83.13% |
3 Yr | -2.0%* | -19.8% | 19.7% | 56.49% |
5 Yr | 3.0%* | -13.5% | 15.3% | 46.62% |
10 Yr | 5.3%* | -6.0% | 16.6% | 52.83% |
* Annualized
Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2022 | -14.4% | -53.9% | 11.7% | 69.09% |
2021 | 0.3% | -22.3% | 18.5% | 52.15% |
2020 | 4.3% | -4.7% | 41.4% | 55.84% |
2019 | 4.5% | -10.2% | 13.1% | 65.22% |
2018 | -0.2% | -5.7% | 26.9% | 29.55% |
Total Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -2.0% | -41.2% | 24.5% | 73.74% |
1 Yr | -9.0% | -28.9% | 28.3% | 83.62% |
3 Yr | -2.0%* | -19.8% | 19.7% | 57.67% |
5 Yr | 3.0%* | -13.5% | 15.3% | 49.30% |
10 Yr | 5.3%* | -6.0% | 16.6% | 65.42% |
* Annualized
Total Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2022 | -14.4% | -53.9% | 11.7% | 69.09% |
2021 | 0.3% | -22.3% | 18.5% | 52.15% |
2020 | 4.3% | -4.7% | 41.4% | 55.84% |
2019 | 4.5% | -10.2% | 13.1% | 65.94% |
2018 | -0.2% | -5.7% | 26.9% | 36.36% |
NAV & Total Return History
SHSCX - Holdings
Concentration Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Assets | 9.49 B | 732 K | 46.2 B | 5.85% |
Number of Holdings | 150 | 3 | 507 | 12.18% |
Net Assets in Top 10 | 4.17 B | 2.18 K | 21.6 B | 6.60% |
Weighting of Top 10 | 41.45% | 12.3% | 100.0% | 61.93% |
Top 10 Holdings
- UnitedHealth Group Inc 9.44%
- Johnson & Johnson 4.46%
- Eli Lilly and Co 4.02%
- Thermo Fisher Scientific Inc 3.94%
- Pfizer Inc 3.79%
- Abbott Laboratories 3.45%
- AbbVie Inc 3.26%
- Cigna Corp 3.09%
- Danaher Corp 3.05%
- Medtronic PLC 2.98%
Asset Allocation
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Stocks | 96.90% | 0.09% | 106.13% | 79.19% |
Cash | 2.30% | -0.10% | 99.91% | 23.86% |
Other | 0.80% | -22.99% | 3.38% | 15.74% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 26.90% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 28.43% |
Bonds | 0.00% | 0.00% | 12.39% | 24.87% |
Stock Sector Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Healthcare | 98.96% | 26.56% | 100.00% | 74.11% |
Basic Materials | 0.73% | 0.00% | 14.83% | 15.23% |
Financial Services | 0.31% | 0.00% | 8.43% | 8.63% |
Utilities | 0.00% | 0.00% | 1.52% | 22.84% |
Technology | 0.00% | 0.00% | 28.70% | 29.95% |
Real Estate | 0.00% | 0.00% | 7.13% | 28.43% |
Industrials | 0.00% | 0.00% | 7.02% | 27.92% |
Energy | 0.00% | 0.00% | 0.00% | 22.34% |
Communication Services | 0.00% | 0.00% | 12.28% | 26.90% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 31.98% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 27.92% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
US | 90.61% | 0.09% | 104.41% | 26.40% |
Non US | 6.29% | 0.00% | 45.40% | 80.20% |
SHSCX - Expenses
Operational Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.84% | 0.08% | 3.13% | 8.54% |
Management Fee | 0.67% | 0.00% | 1.25% | 56.38% |
12b-1 Fee | 1.00% | 0.00% | 1.00% | 81.61% |
Administrative Fee | 0.07% | 0.03% | 0.25% | 18.42% |
Sales Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | 1.00% | 1.00% | 5.00% | 57.14% |
Trading Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 18.67% |
SHSCX - Distributions
Dividend Yield Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 2.44% | 40.10% |
Dividend Distribution Analysis
SHSCX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Monthly | Semi-Annually |
Net Income Ratio Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.77% | -2.54% | 1.92% | 84.48% |
Capital Gain Distribution Analysis
SHSCX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
SHSCX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
18.85
18.9%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.17 | 2.12 |